| Name | 2-methyl-1,2,3,5-tetrahydro-1,5-benzodiazepine-4-thione |
|---|---|
| Synonyms |
1H-1,5-BENZODIAZEPINE-2-THIONE,2,3,4,5-TETRAHYDRO-4-METHYL
4-Methyl-1H-tetrahydro-1,5-benzodiazepine-2-thione |
| Density | 1.21g/cm3 |
|---|---|
| Boiling Point | 315.6ºC at 760 mmHg |
| Molecular Formula | C10H12N2S |
| Molecular Weight | 192.28100 |
| Flash Point | 144.6ºC |
| Exact Mass | 192.07200 |
| PSA | 63.19000 |
| LogP | 2.42410 |
| Index of Refraction | 1.649 |
|
~83%
74389-71-2 |
| Literature: CONSTELLATION PHARMACEUTICALS, INC.; ALBRECHT, Brian, K.; GEHLING, Victor, S.; HEWITT, Michael, C.; TAYLOR, Alexander, M.; HARMANGE, Jean-Christophe Patent: WO2012/151512 A2, 2012 ; Location in patent: Page/Page column 121; 179 ; |
|
~%
74389-71-2 |
| Literature: CONSTELLATION PHARMACEUTICALS, INC.; ALBRECHT, Brian, K.; GEHLING, Victor, S.; HEWITT, Michael, C.; TAYLOR, Alexander, M.; HARMANGE, Jean-Christophe Patent: WO2012/151512 A2, 2012 ; |
|
~%
74389-71-2 |
| Literature: CONSTELLATION PHARMACEUTICALS, INC.; ALBRECHT, Brian, K.; GEHLING, Victor, S.; HEWITT, Michael, C.; TAYLOR, Alexander, M.; HARMANGE, Jean-Christophe Patent: WO2012/151512 A2, 2012 ; |